Since it has been discovered that MDM2 and p53 are part of an auto-regulatory feedback loop, a new approach for cancer treatment consists of stimulating p53 by inhibiting its interaction with MDM2 (Wu et al., 1993). The gene discussed is TP53; the disease is cancer.